Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
Frontier Biotechnologies Inc. has issued a notice regarding abnormal fluctuations in its stock trading. The company reported that its stock price had deviated significantly over three consecutive trading days, triggering regulatory scrutiny. Despite the fluctuations, the company confirmed that its daily operations remain normal and there are no undisclosed significant events affecting its stock price. The board has assured investors of the accuracy and completeness of the information provided in the announcement.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/frontier-biotechnologies-incannouncement-on-abnormal-fluctuations-in-stock-trading
Frontier Biotechnologies Inc. on 6ix
Earlier from Frontier Biotechnologies
- Announcement on Reply to the Supervision and Inquiry Letter Regarding Information Disclosure of the 2025 Annual Report
- Announcement on Resolutions of the 2025 Annual General Meeting
- Correction Announcement on Preliminary Earnings Estimate for 2025 and Earnings Preannouncement
- Announcement on Changing the Disclosure Time of 2025 Annual Report and Report for Q1 2026
- Announcement on Conducting Foreign Exchange Derivatives Trading Business
Later from Frontier Biotechnologies
- Announcement on Returning Idle Raised Funds Used to Temporarily Supplement Current Capital
- Indicative Announcement on Change in Equity of Shareholders Holding More Than 5% of the Shares Reaching 1% and 5% Threshold
- Voluntary Disclosure Announcement on Obtaining Drug Registration Certificate for FB3002 Loxoprofen Sodium Patches
- Announcement on Use of Temporarily Idle Raised Funds for Cash Management
- Announcement on Return of Idle Raised Funds Temporarily Used to Supplement Working Capital
Follow Frontier Biotechnologies into a list and get an email when it puts out news.
Follow Frontier Biotechnologies